Symptomatic ascites after discontinuation of continuous peritoneal dialysis. 1997

M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
Medical Service and Urology Section, Albuquerque Veterans Affairs Medical Center, and University of New Mexico School of Medicine, 87108, USA.

OBJECTIVE To analyze pathogenetic associations, clinical features, management, and outcome of ascites following discontinuation of continuous peritoneal dialysis (CPD). METHODS Retrospective analysis of symptomatic ascites, defined as ascites requiring at least one therapeutic paracentesis, developing in patients who discontinued CPD. METHODS Dialysis unit of one tertiary care center. METHODS Twelve patients with 13 episodes of symptomatic ascites diagnosed soon after (a few days to 2 months) discontinuation of CPD. METHODS Diagnostic tests to characterize the pathogenesis of ascites; management of ascites by hemodialysis or CPD. METHODS Evolution of clinical features and nutritional parameters, survival. RESULTS Ascites was infectious in 3 episodes (non-tuberculous mycobacterial peritonitis) and noninfectious in the remaining 10 episodes. Serum-to-ascites albumin concentration gradient (AG) was 6.3 +/- 1.5 g/L in infectious ascites and 17.3 +/- 2.7 g/L ( >11 g/L in every episode) in noninfectious ascites. Infectious ascites was managed with hemodialysis, prolonged courses of antimicrobial agents, and repeated paracentesis. Paracentesis ceased after 3-9 months. The patients were alive after 52 +/- 19 months. Seven episodes of noninfectious ascites were managed by hemodialysis and repeated paracentesis. Five patients died within 6 months from cardiac causes or sepsis. The remaining 2 patients died after 14 and 16 months from cardiac causes. Three episodes of noninfectious ascites in 2 patients were treated by restarting CPD within 2-5 months. Patients were alive at 16.9 +/- 13.2 months. They were asymptomatic and achieved fluid control. On the same CPD schedule, peritoneal clearances of urea and creatinine and normalized protein nitrogen appearance were unchanged between the initial and restarted CPD. Serum albumin was 33.3 +/- 2.5 g/L at the end of the first CPD period, 23.6 +/- 2.5 g/L soon after restarting CPD, and 31.3 +/- 5.5 g/L 4 months after restarting CPD. CONCLUSIONS Noninfectious ascites after discontinuation of CPD is often characterized by an AG > 11 g/L, suggesting portal hypertension. Restarting CPD in noninfectious ascites may be associated with improvement in ascites symptomatology and nutritional parameters and with satisfactory survival.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.

Related Publications

M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
July 1981, Archives of internal medicine,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
November 2020, Renal failure,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
May 2019, The journal of vascular access,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
January 2014, Internal medicine (Tokyo, Japan),
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
January 1996, Nephron,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
August 1995, Journal of the American Society of Nephrology : JASN,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
January 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
January 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
M Z Haq, and A H Tzamaloukas, and D Malhotra, and L J Gibel
January 2001, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
Copied contents to your clipboard!